Analyzing bone marrow samples from 20 MM patients using flow cytometry, we found that, in agreement with previous observations5,7–9, CD229 shows equally strong expression on the surface of MM cells from all patients with newly diagnosed and relapsed/refractory disease (Fig. 1a). Here, LY9 is linked to Miyoshi myopathy.